ZHOU Ling-yun, DENG Sheng, XU Ping, LI Xin, YAN Ying, OUYANG Lin-qi, LIU Xiang, HE Ge-fei, CHEN Yan-ping, SHI Zhi-hua, WANG An-fa, HUANG Yu, WANG Li-xin, HE Yi-feng, ZHANG Ji-hong, GUO Yan, ZUO Xiao-cong
Oral calcium channel blocker (CCB) is the most common long-term medication for cardiovascular diseases. Consequently, it is essential to construct a scientific and standardized clinical comprehensive evaluation system, and then formulate Expert Consensus on Clinical Comprehensive Evaluation of Oral CCBs to assist decision-making for the government and clinicians. The Third Xiangya Hospital of Central South University has organized the formulation of this expert consensus based on the Guideline for Clinical Comprehensive Evaluation of Medicine and Technical Guidelines for Clinical Comprehensive Evaluation of Medicine of Cardiovascular Diseases with the participation of 16 representative medical institutions in Hunan. The expert consensus systematically evaluated oral CCBs, especially in the therapy of hypertension and coronary artery diseases, from 6 dimensions, including safety, effectiveness, economy, accessibility, suitability and innovation. This expert consensus can provide a decision-making basis for the clinical rational drug use and selection of drugs for medical institutions, and provide reference for the construction of comprehensive evaluation system of other drugs.